Unimartpharma Private Limited
About Unimartpharma Private Limited
Data last updated:
Unimartpharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2020PTC339828. Its GSTIN is 27AACCU5915D1ZG (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Pradeep Kumar Singh and Ajay Kumar Sahu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hedf E 80 7 10 Plot No 387 Patel Nagar Mar Hind Mandal Golibar Colony, Mumbai, Maharashtra, India – 400055.
As per the financials filed for FY 2024, the company reported a revenue of ₹41.33 Lakh. For the same year it recorded a net profit of ₹60,057 (net margin 1.5%) and EBITDA of ₹86,787 (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 41% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHedf E 80 7 10 Plot No 387 Patel Nagar Mar Hind Mandal Golibar Colony, Mumbai, Maharashtra, India – 400055
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Unimartpharma Private Limited
The main business activity of Unimartpharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Unimartpharma Private Limited FY 2025 filings available
Unimartpharma Private Limited reported revenue of ₹41.33 Lakh for FY 2024.
Compounded Annual Growth Rate (CAGR) of Unimartpharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 41% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Unimartpharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹86,787 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹60,057 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Unimartpharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.1% | •••• | •••• | •••• |
| Net Profit Margin | 1.5% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Unimartpharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Unimartpharma Private Limited
Unimartpharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pradeep Kumar Singh | Director | 19 May 2020 | 6 Years 5 Months | Current |
| Ajay Kumar Sahu | Director | 19 May 2020 | 6 Years 5 Months | Current |
Peer Comparison of Unimartpharma Private Limited
Unimartpharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Big Laboratories Private Limited | ₹41.45 Lakh (FY 2021) | •••• | •••• | -48.0% | •••• | New Delhi, Delhi, India |
| Genlyfe Healthcare Private Limited | ₹41.44 Lakh (FY 2024) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Genomics Healthcare Private Limited | ₹41.41 Lakh (FY 2020) | •••• | •••• | 30.0% | •••• | Howrah, West Bengal, India |
| Glary Pharmaceuticals Private Limited | ₹41.39 Lakh (FY 2024) | •••• | •••• | 47.0% | •••• | Lucknow, Uttar Pradesh, India |
| Nextgen Pharmaceutical and Formulations Private Limited | ₹41.35 Lakh (FY 2024) | •••• | •••• | 14.0% | •••• | Indore, Madhya Pradesh, India |
| Unimartpharma Private Limited this company | ₹41.33 Lakh (FY 2024) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Sarv Shakti Ayurvedic Pharmaceuticals Private Limited | ₹41.25 Lakh (FY 2016) | •••• | •••• | 13.0% | •••• | Amritsar, Punjab, India |
| Healthscape Business Solutions Private Limited | ₹41.16 Lakh (FY 2024) | •••• | •••• | -32.0% | •••• | New Delhi, Delhi, India |
| Khlorophylls Biotech Private Limited | ₹41.12 Lakh (FY 2024) | •••• | •••• | 13.0% | •••• | Vadodara, Gujarat, India |
| XL Lifeline Private Limited | ₹41.08 Lakh (FY 2024) | •••• | •••• | 58.0% | •••• | Bhubaneswar, Odisha, India |
| Zedon Pharmaceuticals Private Limited | ₹41.05 Lakh (FY 2025) | •••• | •••• | 45.0% | •••• | Bhopal, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Unimartpharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Unimartpharma Private Limited
Unimartpharma Private Limited is audited by DEEPAK JHA & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DEEPAK JHA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Unimartpharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Unimartpharma Private Limited
Unimartpharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Unimartpharma Private Limited
Unimartpharma Private Limited has a workforce of 0 employees as of Apr 05, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Unimartpharma Private Limited
Unimartpharma Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Pankaj Goswami ceased to be Director on 05 Aug 2022.
Credit Ratings, Litigation & Regulatory Alerts for Unimartpharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Unimartpharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Unimartpharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Unimartpharma Private Limited
Unimartpharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCU5915D1ZG | Maharashtra | Active | 03 Aug 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Unimartpharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Unimartpharma Private Limited
Unimartpharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 May 2020 (6+ years old) and is registered under CIN U51909MH2020PTC339828.
Unimartpharma reported revenue of ₹41.33 Lakh for FY 2024.
Unimartpharma has 2 current directors:
- Pradeep Kumar Singh - Director
- Ajay Kumar Sahu - Director
Unimartpharma reported a net profit of ₹60,057 (net margin 1.5%) and EBITDA of ₹86,787 (EBITDA margin 2.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Unimartpharma is 41% over three years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Unimartpharma is 27AACCU5915D1ZG, registered in Maharashtra.
The CIN (Corporate Identification Number) of Unimartpharma is U51909MH2020PTC339828. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unimartpharma was incorporated on 19 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Unimartpharma by revenue are Big Laboratories Private Limited, Genlyfe Healthcare Private Limited, Genomics Healthcare Private Limited, Glary Pharmaceuticals Private Limited, Nextgen Pharmaceutical and Formulations Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Pankaj Goswami ceased to be Director on 05 Aug 2022. Ajay Kumar Sahu was appointed as Director on 19 May 2020. Pradeep Kumar Singh was appointed as Director on 19 May 2020.
The registered office of Unimartpharma is at Hedf E 80 7 10 Plot No 387 Patel Nagar Mar Hind Mandal Golibar Colony, Mumbai, Maharashtra, India – 400055.